Evaluating Serum Troponin as a Mortality Predictor in COVID-19: Two Center Prospective Study
DOI:
https://doi.org/10.32007/jfacmedbaghdad2171Keywords:
Asthma , Heart Diseases, Myocardial Ischemia, SARS-CoV-2 , Smokers, Angiotensin-Converting Enzyme 2Abstract
Background: Severe Acute Respiratory Syndrome Corona Virus 2 induced by a combination of the spike protein of the virus and an angiotensin-converting enzyme 2, which is strongly expressed in the heart and lungs, causing acute myocardial injury with increase serum Troponin level. The identification of a significant cardiac involvement might activate the doctor in cardiology department for follow-up during hospitalization or after COVID-19 recovery.
Objectives: evaluating serum troponin as a mortality predictor in COVID-19: two center prospective study.
Methods: A prospective observational study was carried out in Al Yarmouk Teaching Hospital and Dar Al-Salam Hospital, Al-Karkh side of Baghdad-Iraq from 1st of January 2021 to 30th of June 2021 and involved (85) patients confirmed to have COVID-19 by RT-PCR, then screened for cardiac-specific biomarkers as reflected by elevated serum troponin level. Microsoft Excel 2010 and Statistical package for social sciences version 23 were used for data entry. Chi square and t-test was used was used to compare proportions, analyzing data and show any significant difference of the mean age.
Results: In this study, 24 (28.2%) patients were with high serum troponin level and the majority 61 (71.8%) were with normal serum troponin level. The highest proportion of high serum troponin level was among smokers and ex-smokers [55.6% (5), and 66.7% (2) respectively. 12 (46.2%) of patients with diabetes were with high serum troponin level. 62.5% (15) of hypertensive patients were significantly with high troponin level (P= 0.018). There was a strong association between COVID-19 severity and serum troponin level whereas in patients with critical COVID-19 60.9% (14) were within high serum troponin level. There was a significant difference between the outcome of COVID-19 patients and serum troponin level, where the higher serum troponin was in 14 (60.9%) from patients who ended up with death.
Conclusion: The study showed a significant relationship between high serum troponin levels and mortality in critical COVID-19 patients. High serum troponin level was significantly associated with diabetes mellitus, hypertension, ischemic heart disease, and smoking. There was no significant association between high serum troponin level and age, sex, asthma, and malignancy.
Received: Jun. 2023
Revised: Oct. 2024
Accepted: May 2025
Published Online: May 2025
Published: July 2025
Downloads
References
1. Bessière F, Roccia H, Delinière A, Charrière R, Chevalier P, Argaud L. Assessment of QT Intervals in a Case Series of Patients with Coronavirus Disease 2019 (COVID-19). JAMA cardiology. 2020 Sep 1;5(9):1067–106947. https://doi.org/10.1001/jamacardio.2020.1738.
2. Siddiqi HK, Mehra MR. Transplantation L. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. The J Heart Lung Transplant. 2020 May;39(5):405. https://doi.org/10.1016/j.healun.2020.03.012.
3. Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA cardiology. 2020 Nov 1;5(11):1281–1285. https://doi.org/10.1001/jamacardio.2020.3551.
4. Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B. ST-segment elevation in patients with Covid-19—a case series. New England Journal of Medicine. 2020 Jun 18;382(25):2478–2480 https://doi.org/10.1056/NEJMc2009020.
5. Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. European journal of heart failure. 2020 May;22(5):911–915. https://doi.org/10.1002/ejhf.1828.
6. Ranard LS, Ahmad Y, Masoumi A, Chuich T, Romney M-LS, Gavin N. Clinical pathway for management of suspected or positive novel coronavirus-19 patients with ST-segment elevation myocardial infarction. Critical pathways in cardiology. 2020;19(2):49–54. https://doi.org/10.1097/HPC.0000000000000223.
7. Living guidance for clinical management of COVID-19: Living guidance, 23 November 2021 – World Health Organization (WHO) 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2.
8. Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al.. Gender Differences in Patients with COVID-19: Focus on Severity and Mortality. FPubH. 2020; 8:152 https://doi.org/10.3389/fpubh.2020.00152.
9. Xu XW, Wu XX, Jiang XG, et al.. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:0 https://doi.org/10.1136/bmj.m606.
10. Mahmood ZS, FadhilHY, Ad′hiah AH. Estimation of Hematological Parameters of Disease Severity in Iraqi Patients with COVID-19. IJS. 2021; 62(10): 3487-3496. https://doi.org/10.24996/ijs.2021.62.10.8.
11. Ayad M. Ali,Hassan M. Rostam,Mohammed H. Fatah. Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients 22. Immunity inflammation and disease.2021. https://doi.org/10.1002/iid3.582.
12. Gur A, Ulutas Z. Characteristic Electrocardiography Findings of COVID-19 Patients. Arch Iran Med. 2021 Sep 1;24(9):706-712. https://doi.org/10.34172/aim.2021.103.
13. Angeli F, Spanevello A, De Ponti R, Visca D, Marazzato J, Palmiotto G, Feci D, Reboldi G, Fabbri LM, Verdecchia P. Electrocardiographic features of patients with COVID-19 pneumonia.Eur J Intern Med. 2020. https://doi.org/10.1016/j.ejim.2020.06.015.
14. Pizzini PA, Burkert F, Theurl I, Weiss G, Bellmann-Weiler RJH rognostic impact of high sensitive Troponin T in patients with influenza virus infection: a retrospective analysis.. Heart Lung. 2020; 49:105–109 https://doi.org/10.1016/j.hrtlng.2019.05.009
15. Yang X, Yu Y, Xu J. Clinical course and outcomes of critically ill patients with SARS‐CoV‐2 pneumonia in Wuhan, China: a single‐ centered, retrospective, observational study. Lancet Respir Med. 2020; 8:475‐481. https://doi.org/10.1016/S2213-2600(20)30079-5.
16. Wu Z., McGoogan J. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020; 323(13): 1239. https://doi.org/10.1001/jama.2020.2648.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Muhannd M. Jawad, Abbas N. Al-Shirifi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution 4.0 International license..
